Document is current
Any future updates will be listed below
-
Authors
Edgerley, Sarah
Zhu, Rongbo
Quidwai, Ariba
Kim, Harold
Jeimy, Samira https://orcid.org/0000-0002-3425-1874
- License Information
-
More Information
Article History
Received: 18 November 2021
Accepted: 8 February 2022
First Online: 21 February 2022
Declarations
:
: Not applicable.
: Not applicable.
: SE has no relevant conflicts of interest to declare. RZ has no relevant conflicts of interest to declare. AQ has no relevant conflicts of interest to declare. HK has been on the speakers’ bureau and/or advisory boards for ALK, Aralez, Astra Zeneca, GSK, Kaleo, Mylan, Pediapharm, Pfizer, and Stallergenes Greer. SJ has been on the speakers’ bureaus for Aralez, Novartis, Astra Zeneca, and Sanofi, and on the national advisory board for Sanofi.
